Other battles

Online privacy, clean air, affordable housing, whistleblower protection and much more: which other corporate lobby fights are putting EU public interest on the line?

EU institutions

Extreme finance: the far-right and its funding

05.05.2015

Money matters in Europe's far-right.

Towards legalised corporate secrecy in the EU?

27.04.2015

How industry, law firms and the European Commission worked together on EU “trade secrets” legislation.

EU draft trade secrets directive threat to free speech, health, environment and worker mobility

23.03.2015

Multi-sectoral civil society coalition calls for greater protections for consumers, journalists, whistleblowers, researchers and workers.

Les affaires au secret

28.01.2015

Va-t-on assister à l'apparition d'un label « secrets des affaires » pour les entreprises, comparable au « secret défense » des états ? Ce dernier leur permet de s'opposer à la publication de certaines informations jugées trop sensibles, et de poursuivre en justice ceux qui se risqueraient à les publier sans son autorisation. L'utilisation possible de tels outils contre des lanceurs d'alerte, journalistes, syndicalistes... fait craindre une régression importante.

EU trade secrets directive threat to health, environment, free speech and worker mobility

17.12.2014

A new draft EU directive currently looked at by the European Parliament wants to protect companies' "trade secrets", but poses several dangerous threats.

Environment

Leaked Draft Commission Work Programme 2015

15.12.2014

CEO obtained a scanned copy of the Leaked Draft Commission Work Programme 2015, containing controversial plans to scrap EU proposals for environmental and social legislation.

EU institutions

How to improve scientific advice to the European Commission?

19.11.2014

The position of Chief Scientific Adviser to the President of the European Commission has been discontinued, and the Juncker Commission says it is now reflecting on how to organise independent scientific advice. This is a crucial issue and, together with many other NGOs, we sent a list of principles to the Commission on how to, in our opinion, try to best do this.

The crusade against 'red tape': How the European Commission and big business push for deregulation

31.10.2014

A crusade for big business-friendly deregulation, waged during José Manuel Barroso's Presidency of the European Commission, shows no signs of stopping. This neoliberal push to weaken or block new legislation appears likely to expand with Jean-Claude Juncker's new Commission team.

Health

The EU Chief Scientific Adviser and endocrine disrupting chemicals

29.10.2014

Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.

Health

Will Barroso provide answers about tobacco industry contacts before leaving the Berlaymont?

16.10.2014

As part of her inquiry into the Commission's implementation of UN tobacco lobby rules, European Ombudsman Emily O'Reilly has asked Commission President Barroso for “a supplementary opinion” with proper answers to questions raised in her inquiry. O'Reilly took this step after having received a seriously unconvincing letter from Barroso that fails to address the specific questions and arguments put forward by CEO in the complaint that sparked the Ombudsman's inquiry.

Health

Chemical conflicts: Inadequate independence policies for EU's expert risk assessors

25.09.2014

New research on the safety assessment of four controversial chemicals shows that two thirds (67%) of the scientists involved had at least one, and some many more, conflicts of interest due to their links to industries impacted by the assessments.

Health

Endocrination: new film exposing lobby battle on endocrine disrupting chemicals

12.09.2014

This must-watch film is now online. The film shows how corporations and actors within the Commission are teaming up to demolish a major piece of public health legislation.

Other battles

Extreme finance: the far-right and its funding

Towards legalised corporate secrecy in the EU?

EU draft trade secrets directive threat to free speech, health, environment and worker mobility

Les affaires au secret

EU trade secrets directive threat to health, environment, free speech and worker mobility

Leaked Draft Commission Work Programme 2015

How to improve scientific advice to the European Commission?

The crusade against 'red tape': How the European Commission and big business push for deregulation

The EU Chief Scientific Adviser and endocrine disrupting chemicals

Will Barroso provide answers about tobacco industry contacts before leaving the Berlaymont?

Chemical conflicts: Inadequate independence policies for EU's expert risk assessors

Endocrination: new film exposing lobby battle on endocrine disrupting chemicals

Help us stay independent